Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-04-02
2011-12-13
Kam, Chih-Min (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S350000
Reexamination Certificate
active
08076462
ABSTRACT:
The provision of an antithrombin composition having a desired α-form content rate or β-form content rate is required. The invention provides a process for producing an antithrombin composition having a desired α-form content rate or β-form content rate which is prepared by contacting an antithrombin-containing aqueous solution with a Cellufine Sulfate chromatography carrier.
REFERENCES:
patent: 2010/0113754 (2010-05-01), Sugihara et al.
patent: 0339919 (1989-11-01), None
patent: 2852307 (1990-08-01), None
patent: 2003-520805 (2003-07-01), None
patent: 2003-520806 (2003-07-01), None
patent: 01/53328 (2001-07-01), None
patent: 01/53329 (2001-07-01), None
Extended European Search Report dated Apr. 19, 2010 in European Application No. 08739710.5.
A. Morrica, et al., “Manufacturing process of Anti-thrombin III concentrate: viral safety validation studies and effect of column re-use on viral clearance,” Biologicals, vol. 31, No. 3, pp. 165-173 (2003).
International Search Report (PCT/ISA/210) issued on May 13, 2008 in the corresponding PCT Application No. PCT/JP2008/056600 in the name of Kyowa Hakko Kirin Co., Ltd.
Written Opinion of the International Searching Authority (PCT/ISA/237) issued on May 13, 2008 in the corresponding PCT Application No. PCT/JP2008/056600 in the name of Kyowa Hakko Kirin Co., Ltd.
“Chisso Chromatography Jutenzai Cellufine. Affinity Chromatography-yo Gel. Cellufine Sulfate” Chisso Corp., 2006. pp. 1-3. Retrieved from http://www.chisso.co.jp/fine/jp/cellufine/grade/grade-1.html#02.
Peterson, C. B. et., al. “Isolation and Characterization of an Antithrombin III Variant with Reduced Carbohydrate Content and Enhanced Heparin Binding” The Journal of Biological Chemistry, Jan. 10, 1985, vol. 260, No. 1, pp. 610-615.
Lindsay, M et., al. “Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations” Journal of Chromatography A, 2004, vol. 1026, pp. 149-157.
Mochizuki, S. et., al. “Purification and characterization of recombinant human antithrombin containing the prelatent form in Chinese hamster ovary cells” Protein Expression and Purification, 2005, vol. 41, pp. 323-331.
Edmunds, T. et., al. “Transgenically Produced Human Antithrombin: Structural and Functional Comparison to Human Plasma—Derived Antithrombin”, Blood, Jun. 15, 1998, vol. 91, No. 12, pp. 4561-4571.
Japanese Patent Office, Application No. JP 2009-507556, Notification of Reasons for Refusal dated Apr. 26, 2011 (in the name of Kyowa Hakko Kirin Co., Ltd.).
European Search Report issued on Jun. 20, 2011 in the corresponding European Patent Application No. 08739710.5.
Onodera Setsuko
Sugihara Tsutomu
Suzawa Toshiyuki
Urakubo Tomonari
Kam Chih-Min
Kyowa Hakko Kirin Co., Ltd
Sughrue & Mion, PLLC
LandOfFree
Method for producing antithrombin composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing antithrombin composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing antithrombin composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4303304